Pharma
Webinar: Molecular docking: Extrapolating to new scaffolds with Surflex-Dock
Interested in improving your binding mode predictions? Surflex-Dock is a unique method for molecular docking, offering automatic pipelines for ensemble docking, applicable to both small molecules and large peptidic macrocycles alike. ...
Optibrium demonstrates superior molecular docking method for small molecules and macrocycles
Surflex-Dock structure-based design method outperforms other molecular docking methods for predicting non-cognate ligand pose of macrocyclic compounds Results published Open Access in Journal of Computer-Aided Molecular Design ...
The impact of AI on the event production industry: jobs created and lost
Every event we’ve worked on in the last 12 months has in some way mentioned AI (except Munich Beer Festival and Top Clown UK). ...
The National Health Service (NHS) UK: Health & MedTech Opportunities
Explore the opportunities within the UK's National Health Service (NHS) for health and MedTech businesses! ...
ESMO 2024 review: Improving patient survival through innovations in oncology
European Society for Medical Oncology (ESMO) Congress 2024 was held in Barcelona, Spain, bringing together the global oncology community to share the latest data, innovations, and advancements in cancer care. ...
Psoriasis patient source of business for major IL-17 agents
Source of business for leading IL-17 agents in psoriasis varies significantly by brand. While the majority of Cosentyx patients are previously treated with a TNF inhibitor, a sizable portion of Taltz patients have tried another IL-17 agent before starting Taltz. This finding suggests a ...
Implications of the Inflation Reduction Act for cancer medicine development
The Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program (MDPNP) directs the Secretary of Health and Human Services (HHS) to set a maximum price for certain drugs in Medicare. The MDPNP is expected to reduce the pharmaceutical company revenues in Medicare from a selecte...
Nuclera closes $75 million USD financing
Series C round led by Elevage Medical Technologies. Funding will accelerate the commercialization of Nuclera’s eProtein Discovery platform, to optimize protein expression and purification workflows within research labs globally. ...
Benefits of a Nitrosamine Selective Detector
Nitrosamines, such as N-Nitrosodimethylamine (NDMA), are carcinogenic compounds that can form during the drug manufacturing process and storage under certain conditions. These contaminants pose significant health risks, and their presence in medications like Ranitidine has alr...
Guardtech Group bag third win in two months with West Suffolk Innovation of the Year Award
Haverhill-based cleanroom construction specialists scoop Bury Free Press Awards win for Innovation with portable container business Cleancube Mobile Cleanrooms ...